Teva Pharmaceutical Industries Ltd
TEVA16.990USD
-0.730-4.12%
Cierre 06/13, 16:00（ET）Cotizaciones retrasadas 15 min
19.26BCap. mercado
PérdidaP/E TTM
Más Datos de Teva Pharmaceutical Industries Ltd Compañía
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Información de la empresa
Símbolo de cotizaciónTEVA
Nombre de la empresaTeva Pharmaceutical Industries Ltd
Fecha de salida a bolsaJan 01, 1951
Fundada en1944
Director ejecutivoMr. Richard D. Francis
Número de empleados33892
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 01
Dirección124 Dvora Hanevi'a St.
CiudadTEL AVIV-YAFO
Bolsa de valoresTel Aviv Stock Exchange
PaísIsrael
Código postal6944020
Teléfono97239148213
Sitio Webhttps://www.tevapharm.com/
Símbolo de cotizaciónTEVA
Fecha de salida a bolsaJan 01, 1951
Fundada en1944
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
11.91K
--
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
11.91K
--
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de abr
Divisa: USDActualizado: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Generic products
9.46B
57.19%
AUSTEDO
1.69B
10.20%
Anda
1.54B
9.28%
Other
1.38B
8.32%
AJOVY
507.00M
3.06%
Other
1.98B
11.94%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
8.03B
48.56%
Europe
5.10B
30.85%
International Markets
2.46B
14.89%
Other
944.00M
5.71%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Generic products
9.46B
57.19%
AUSTEDO
1.69B
10.20%
Anda
1.54B
9.28%
Other
1.38B
8.32%
AJOVY
507.00M
3.06%
Other
1.98B
11.94%
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
6.57%
Ion Asset Management Israel Ltd
3.40%
Clal Insurance Enterprises Holdings Ltd.
3.30%
BlackRock Institutional Trust Company, N.A.
2.88%
Menora Mivtachim Insurance Ltd.
2.55%
Other
81.31%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
6.57%
Ion Asset Management Israel Ltd
3.40%
Clal Insurance Enterprises Holdings Ltd.
3.30%
BlackRock Institutional Trust Company, N.A.
2.88%
Menora Mivtachim Insurance Ltd.
2.55%
Other
81.31%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
27.44%
Hedge Fund
13.25%
Investment Advisor/Hedge Fund
11.79%
Insurance Company
4.85%
Research Firm
2.85%
Pension Fund
1.63%
Family Office
1.32%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.25%
Other
35.78%
Participación institucional
Actualizado: lun., 20 de ene
Actualizado: lun., 20 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1095
724.51M
63.17%
+11.84M
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
2023Q1
927
576.84M
51.93%
-50.26M
2022Q4
946
573.39M
51.61%
-69.40M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
76.01M
6.63%
+14.91M
+24.41%
Dec 31, 2024
Ion Asset Management Israel Ltd
36.65M
3.2%
+409.78K
+1.13%
Dec 31, 2024
Clal Insurance Enterprises Holdings Ltd.
38.96M
3.4%
+4.42M
+12.79%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
33.10M
2.89%
+786.74K
+2.43%
Dec 31, 2024
Menora Mivtachim Insurance Ltd.
28.38M
2.48%
-456.80K
-1.58%
Dec 31, 2024
Lingotto Investment Management LLP
27.19M
2.37%
+688.86K
+2.60%
Dec 31, 2024
Phoenix Investment and Finances Ltd
21.21M
1.85%
-1.35M
-5.98%
Dec 31, 2024
Migdal Insurance and Financial Holdings Ltd
26.04M
2.27%
+569.41K
+2.24%
Dec 31, 2024
Rubric Capital Management LP
17.00M
1.48%
+994.50K
+6.21%
Dec 31, 2024
Ver más
ETFs relacionados
Actualizado: vie., 6 de jun
Actualizado: vie., 6 de jun
Nombre
Proporción
VanEck Israel ETF
8.19%
iShares MSCI Israel ETF
6.8%
Tema Neuroscience and Mental Health ETF
4.42%
Amplify Weight Loss Drug & Treatment ETF
4.05%
VanEck Pharmaceutical ETF
3.94%
ARK Israel Innovative Technology ETF
2.06%
Janus Henderson Securitized Income ETF
0.87%
WisdomTree International Multifactor Fund
0.7%
iShares MSCI Intl Value Factor ETF
0.43%
iShares Health Innovation Active ETF
0.27%
Ver más
VanEck Israel ETF
Proporción8.19%
iShares MSCI Israel ETF
Proporción6.8%
Tema Neuroscience and Mental Health ETF
Proporción4.42%
Amplify Weight Loss Drug & Treatment ETF
Proporción4.05%
VanEck Pharmaceutical ETF
Proporción3.94%
ARK Israel Innovative Technology ETF
Proporción2.06%
Janus Henderson Securitized Income ETF
Proporción0.87%
WisdomTree International Multifactor Fund
Proporción0.7%
iShares MSCI Intl Value Factor ETF
Proporción0.43%
iShares Health Innovation Active ETF
Proporción0.27%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
